Picture of Xintela AB logo

XINT Xintela AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Xintela Gets Patent Grant In Europe For XSTEM Stem Cell Product

March 17 (Reuters) - Xintela AB  XINT.ST :
    * XINTELA GETS PATENT GRANT IN EUROPE FOR XSTEM STEM CELL
PRODUCT
    * PATENT IS VALID UNTIL YEAR 2038.
    * EUROPEAN PATENT OFFICE (EPO) HAS TODAY APPROVED PATENT
APPLICATION FOR COMPANY'S STEM CELL PRODUCT XSTEM®

Source text for Eikon:  ID:nBQN96qhWt 
Further company coverage:  XINT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 587696600;))

Recent news on Xintela AB

See all news